Pages
Products
GFP Stable Cell Line-Hep3B

GFP Stable Cell Line-Hep3B

Cat.No. :  CSC-RR0127 Host Cell:  Hep3B

Inquire for Price

Cell Line Information

Cell Culture Information

Safety and Packaging

Documents

Cat. No. CSC-RR0127
Description Hep3B was derived from liver of a 8 year-old black male with hepatocellular carcinoma. The GFP Stable Cell Line-Hep3B constitutively expresses GFP.
Host Cell Hep3B
Host Cell Species Homo sapiens (Human)
Stability Validated for at least 10 passages
Reporter Type Fluorescent protein
Application

1. Gene expression studies

2. Protein localization

3. Drug screening and toxicology

4. Live cell imaging

Quality Control Negative for bacteria, yeast, fungi and mycoplasma.
Storage Liquid nitrogen
Recommended Medium Inquiry for instruction of culturing
Revival Rapidly thaw cells in a 37°C water bath. Transfer contents into a tube containing pre-warmed media. Centrifuge cells and seed into a 25 cm2 flask containing pre-warmed media.
Mycoplasma Negative
Format One frozen vial containing millions of cells
Storage Liquid nitrogen
Safety Considerations

The following safety precautions should be observed.

1. Use pipette aids to prevent ingestion and keep aerosols down to a minimum.

2. No eating, drinking or smoking while handling the stable line.

3. Wash hands after handling the stable line and before leaving the lab.

4. Decontaminate work surface with disinfectant or 70% ethanol before and after working with stable cells.

5. All waste should be considered hazardous.

6. Dispose of all liquid waste after each experiment and treat with bleach.

Ship Dry ice
Quick Inquiry

Background

Case Study

Applications

Publications

Q & A

Customer Reviews

GFP is fused with Hep3B Cell Line, researchers can study the behavior and characteristics of these cells in a more detailed and visual manner. The fluorescence emitted by GFP allows researchers to track the movement, distribution, and interactions of the cells within living tissues. This can provide valuable insights into the progression and treatment of liver diseases. Additionally, GFP-tagged Hep3B Cell Line can be used to study gene expression and protein localization within the cells. By monitoring the fluorescence of GFP, researchers can determine the effectiveness of potential therapeutic agents and study their effects on the cells. Hep3B Cell Line is a human hepatocellular carcinoma cell line that has been widely used in liver cancer research. It was first established in 1977 and has become an important model for studying the pathogenesis and treatment of hepatocellular carcinoma. Some of the major advantages of using Hep3B cells include rapid growth, ease of culture, and karyotypic stability. These cells also exhibit a high degree of tumourigenicity, making them suitable for preclinical studies of cancer therapy. In addition, Hep3B cells express a wide range of cell surface antigens, making them suitable for immune-based studies. In conclusion, the Hep3B Cell Line is an important tool for understanding and treating hepatocellular carcinoma.

Histone modifications are critical for the regulation of chromatin function. Histone modifications affect key biological processes such as gene expression, repair, and the cell cycle by altering the structure and function of chromatin. Researchers used the GFP Stable Cell Line-Hep3B cell line to explore the role of JMJD2A, a demethylating enzyme that is normally overexpressed in tumors, in hepatocellular carcinoma cells, and showed that it accelerated malignant progression. Through an epigenetic mechanism, JMJD2A promoted the expression and maturation of pre-miR372. miR372 formed a new transcript of JMJD2A (JMJD2AΔ) by blocking exon 13-intron-14 editing. jmjd2a inhibited P21 by reducing H3K9me3-dependent JMJD2AΔ (WAF1/Cip1) expression, thereby enhancing Pim1 transcription. Further, JMJD2A promoted the interaction of pRB, CDK2, and CyclinE to drive C-myc transcription and translation by increasing Pim1 expression. This study reveals a novel mechanism of JMJD2A in hepatocellular carcinoma cells, pointing to its potential as a new therapeutic target for hepatocellular carcinoma.

Figure 1 depicts the experimental results of JMJD2A in accelerating the growth of hepatocellular carcinoma cells in vitro, including the transfection of Hep3B cell line, RT-PCR and Western blot results, cell proliferation assay, BrdU assay, and the assessment of colony forming ability. (doi: 10.18632/oncotarget.17095)Figure 1. By constructing two stable Hep3B cell lines (pCMV6-AC-GFP control group and pCMV6-AC-GFP-JMJD2A experimental group), the researchers found that JMJD2A significantly promoted the growth of hepatocellular carcinoma cells. the JMJD2A overexpression group showed higher cell proliferation rate, colony formation efficiency, and BrdU positivity. In addition, JMJD2A overexpression significantly increased the weight of xenograft tumors and increased the proportion of undifferentiated cells. This indicated that JMJD2A accelerated the malignant progression of hepatocellular carcinoma cells. (An J, et al., 2019)

The GFP stable Hep3B Cell Line, is an important resource for researchers in the fields of hepatology, oncology and cell biology. This cell line is derived from the Hep3B human hepatocellular carcinoma cell line and is genetically modified to stably express green fluorescent protein (GFP). An important application of the GFP-stabilised Hep3B Cell Line, is to study the growth and metastasis of hepatocellular carcinoma (HCC). By labelling cells with GFP, researchers can visually track the growth and migration of Hep3B cells in vitro and in vivo. This helps to study the underlying molecular mechanisms driving HCC progression and identify potential therapeutic targets. In addition, the GFP stable Hep3B Cell Line is also valuable for exploring the role of specific signalling pathways in the development of HCC. the expression of GFP can be regulated by a variety of signalling molecules, allowing researchers to manipulate and study the effects of specific pathways on cell behaviour. This could provide insight into the molecular basis of HCC and contribute to the development of novel diagnostic and therapeutic strategies. In addition, the GFP-stable Hep3B Cell Line, can be used for high-throughput screening of potential anticancer drugs; GFP expression can be used as a readout for cell growth inhibition, which can help to identify novel compounds with anticancer properties. In conclusion, the GFP Stable Cell Line-Hep3B is an invaluable tool for researchers in the fields of hepatology, oncology and cell biology. It enables the visualisation of cell behaviour, the study of signalling pathways and the screening of potential anti-cancer drugs, and is a powerful resource to advance our understanding and treatment of hepatocellular carcinoma and other related diseases.
Customer Q&As
What makes Hep3B Cell Line unique for hepatocellular carcinoma research?

A: Hep3B Cell Line's close resemblance to primary hepatocellular carcinoma cells makes it a valuable model for studying the disease's pathogenesis and for evaluating new treatment strategies.

Are there any potential limitations in using Hep3B Cell Line?

A: While Hep3B Cell Line is a useful model, it is important to consider its limitations, such as potential differences between the cell line and primary tumors, and the need for further validation of research findings using additional models or patient samples.

Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

Customer Reviews
Robust and stable

Perfect for my research needs, the GFP Stable Cell Line - Hep3B is a reliable and valuable tool.

Germany

02/12/2023

Excellent performance

GFP Stable Cell Line-Hep3B produces consistent and clear results and is the first choice for my experiments.

French

05/03/2022

Safe and efficient

GFP Stable Cell Line-Hep3B is easy to manipulate and the data is reliable, giving me confidence in my research.

United Kingdom

10/10/2023

User-friendly and convenient

GFP Stable Cell Line-Hep3B is easy to culture and requires minimal maintenance, saving me time and effort.

Germany

07/31/2022

Great value for money

The GFP Stable Cell Line-Hep3B offers excellent performance at a reasonable price, making it a cost-effective solution for my research work.

Canada

01/13/2020

Write a Review

Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.

Needs improvement

Satisfaction

General satisfaction

Very satisfaction